HomeFOLD • NASDAQ
Follow
Amicus Therapeutics, Inc.
Previous close
$11.86
Day range
$11.49 - $11.93
Year range
$9.70 - $14.57
Market cap
3.48B USD
Avg Volume
3.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 115.08M | 30.63% |
Operating expense | 107.45M | -10.05% |
Net income | -33.84M | 39.42% |
Net profit margin | -29.41 | 53.62% |
Earnings per share | 0.01 | 105.26% |
EBITDA | -1.51M | 96.17% |
Effective tax rate | -6.90% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 286.20M | -2.52% |
Total assets | 777.88M | 7.42% |
Total liabilities | 617.71M | 2.76% |
Total equity | 160.17M | — |
Shares outstanding | 295.38M | — |
Price to book | 21.56 | — |
Return on assets | -1.20% | — |
Return on capital | -1.55% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -33.84M | 39.42% |
Cash from operations | 3.46M | 104.28% |
Cash from investing | -23.96M | 64.08% |
Cash from financing | 8.21M | 1,373.97% |
Net change in cash | -16.20M | 87.39% |
Free cash flow | -7.47M | 88.93% |
About
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Founded
Feb 4, 2002
Website
Employees
517